Sol-Gel Technologies Ltd

Research Sol-Gel Technologies Ltd (SLGL) on Bullrun: market cap USD 243.25M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSLGL
• ExchangeNASDAQ
• CountryIsrael
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 243.25M
• Financial periodFY2025
• RevenueUSD 19.39M
• Revenue growth68.0%
• Net income-USD 6.13M
• Free cash flowUSD 275.00K

Valuation Snapshot

latest market cap is USD 243.25M.

About Sol-Gel Technologies Ltd

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.

Frequently asked questions

What is Sol-Gel Technologies Ltd's market cap?

Sol-Gel Technologies Ltd's market capitalization is USD 243.25M.

What does Sol-Gel Technologies Ltd do?

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally.